Insight Molecular Diagnostics Inc. Common Stock (IMDX) Q1 2024 Annual Earnings
Insight Molecular Diagnostics Inc. Common Stock reported Q1 2024 revenue of $176.0K, missed analyst consensus of $350.0K by $174.0K. Diluted EPS came in at $-1.13, missed the $-0.67 consensus by $0.46.
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Insight Molecular Diagnostics Inc. Common Stock's Q1 2024 earnings report.
Insight Molecular Diagnostics Inc. Common Stock (IMDX) reported Q1 2024 earnings on May 15, 2024 after market close.
Insight Molecular Diagnostics Inc. Common Stock reported revenue of $176.0K and diluted EPS of $-1.13 for Q1 2024.
Revenue missed the consensus estimate of $350.0K by $174.0K. EPS missed the consensus estimate of $-0.67 by $0.46.
You can read the 10-K periodic report (0001493152-24-014720) directly on SEC EDGAR. The filing index links above go to sec.gov.